MEN 10573

Drug Profile

MEN 10573

Latest Information Update: 12 Apr 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Menarini
  • Class Antiasthmatics; Peptides
  • Mechanism of Action Neurokinin 2 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 12 Apr 2000 Discontinued-Preclinical for Asthma in Spain (Unknown route)
  • 31 Aug 1998 No-Development-Reported for Asthma in Spain (Unknown route)
  • 24 Sep 1996 A preclinical study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top